These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 12409983)
1. Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets. Sheu JR; Yeh GC; Fang CL; Lin CH; Hsiao G J Cardiovasc Pharmacol; 2002 Nov; 40(5):743-50. PubMed ID: 12409983 [TBL] [Abstract][Full Text] [Related]
2. Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments. Hsiao G; Shen MY; Fang CL; Chou DS; Lin CH; Chen TF; Sheu JR J Biomed Sci; 2003; 10(3):292-301. PubMed ID: 12711856 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in agonist-induced hyperaggregability of platelets from normal pregnancy. Sheu JR; Hsiao G; Lin WY; Chen TF; Chien YY; Lin CH; Tzeng CR J Biomed Sci; 2002; 9(1):17-25. PubMed ID: 11810021 [TBL] [Abstract][Full Text] [Related]
4. Mechanism involved in the antiplatelet activity of naloxone in human platelets. Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments. Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547 [TBL] [Abstract][Full Text] [Related]
6. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets. Liao CH; Ko FN; Wu CL; Teng CM J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets. Sheu JR; Kan YC; Hung WC; Ko WC; Yen MH Thromb Res; 1997 Nov; 88(3):259-70. PubMed ID: 9526946 [TBL] [Abstract][Full Text] [Related]
8. The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase. Sheu JR; Lee CR; Lin CC; Kan YC; Lin CH; Hung WC; Lee YM; Yen MH Br J Pharmacol; 1999 Jul; 127(5):1206-12. PubMed ID: 10455267 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in the antiplatelet activity of magnesium in human platelets. Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in the antiplatelet activity of midazolam in human platelets. Sheu JR; Hsiao G; Luk HN; Chen YW; Chen TL; Lee LW; Lin CH; Chou DS Anesthesiology; 2002 Mar; 96(3):651-8. PubMed ID: 11873041 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553 [TBL] [Abstract][Full Text] [Related]
12. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related]
13. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950 [TBL] [Abstract][Full Text] [Related]
14. Augmentation of U46619 induced human platelet aggregation by aspirin. Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053 [TBL] [Abstract][Full Text] [Related]
15. Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes. Francesconi M; Scapin M; Casonato A; Girolami A; Deana R Thromb Res; 2000 Nov; 100(4):293-303. PubMed ID: 11113273 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in the antiplatelet activity of ketamine in human platelets. Chang Y; Chen TL; Wu GJ; Hsiao G; Shen MY; Lin KH; Chou DS; Lin CH; Sheu JR J Biomed Sci; 2004; 11(6):764-72. PubMed ID: 15591773 [TBL] [Abstract][Full Text] [Related]
17. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C. Sheu JR; Kan YC; Hung WC; Su CH; Lin CH; Lee YM; Yen MH Thromb Res; 1998 Oct; 92(2):53-64. PubMed ID: 9792112 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945 [TBL] [Abstract][Full Text] [Related]
20. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets. Johnson GJ; Leis LA; Francis GS Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]